The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients

BACKGROUND: Despite its efficacy, FAC regimen may cause fatal cardiotoxicity. Carvedilol may also exert additional antioxidant effects. This study aimed to assess the effect of carvedilol in preventing decline of left ventricular function in breast cancer patients receiving FAC regimen chemotherapy....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Cardiol Heart Vasc
Autores principales: Wibawa Martha, Januar, Soedarsono, Dery A., Iqbal, Mohammad, Astuti, Astri, Martanto, Erwan, Rizki Akbar, Mohammad, Sumantra, I. Gede
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7339049/
https://ncbi.nlm.nih.gov/pubmed/32671185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100575
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares